The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...

Bankrupt drugmaker Purdue Pharma has filed a new bankruptcy plan, a major step towards finalising a proposed opioid settlement of at least $7.4 billion after a setback in the US Supreme Court last ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...

Purdue Pharma Files New Bankruptcy Plan for $7.4 Billion Opioid Settlement By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday ...

Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a $7.4 billion settlement for their role in the opioid crisis. The big picture: ...